Introduction {#S1}
============

Cellular senescence is a complex stress response that renders cells incapable of cell division, even in the presence of growth stimuli ([@R8]). Senescent cells are distinct from quiescent cells, which retain the ability to proliferate in response to appropriate stimuli. Senescent cells are also distinct from post-mitotic cells and terminally differentiated cells, which generally lose the ability to divide as a consequence of developmental, as opposed to stress-activated, programs.

A senescence response is typically induced by cellular damage (often nuclear DNA damage or mitochondrial dysfunction) ([@R63]; [@R68], [@R69]). As part of the senescence response, senescent cells express a number of non exclusive markers, including the cell cycle inhibitor p16^INK4A^ and elevated levels of a lysosomal enzyme termed senescence associated β galactosidase (SA βgal) ([@R45]). Many senescent cells also secrete several cytokines, growth factors, and matrix metalloproteinases, collectively termed the senescence associated secretory phenotype (SASP) ([@R11]), which differ from those secreted by non senescent quiescent, post mitotic, and/or differentiated cells.

Senescent cells can alter tissue homeostasis and promote age related diseases, including degenerative pathologies and cancers ([@R8]; [@R57]). The inability of senescent cells to proliferate can impair tissue regeneration after injury, causing prolonged or permanent tissue damage with age. In addition, the SASP factors that are secreted by senescent cells can alter tissue microenvironments through their paracrine effects and promote age related phenotypes ([@R11]). Indeed, removal of senescent cells in a premature aging mouse model reduced selected age related pathologies such as sarcopenia, cataracts, and loss of subdermal adipose tissue ([@R2]).

While cellular senescence is often viewed as a negative contributor to tissue function during the aging process, senescent cells, and particularly the SASP, can also have beneficial effects, such as the promotion of proper wound healing. This aspect of senescent cells could explain why cellular senescence evolved and has been preserved during evolution, even though it contributes to age related phenotypes later in life. Here, we discuss how cellular senescence can be both beneficial and detrimental during skin aging and wound healing, and how the contrasting cell autonomous and non cell autonomous effects of senescent cells can depend on the physiological context. On the one hand, senescent cells can accelerate aging phenotypes through the loss of tissue homeostasis by promoting chronic inflammation, persistent degradation of the extracellular matrix, and stem cell exhaustion. On the other hand, senescent cells can also play essential roles during wound healing by limiting excessive proliferation and fibrosis and promoting the formation of granulation tissue.

Cellular senescence and skin aging {#S2}
==================================

Skin aging is caused by both intrinsic and extrinsic factors. Intrinsic aging, sometimes termed chronologic aging, refers mainly to sun protected areas of the skin. Intrinsic aging is associated with morphological changes primarily in the epidermal layer, manifest as marked thinning and loss of undulation (flattening of the dermo epidermal junction) ([@R33]). Intrinsic aging also reduces subcutaneous fat and dermal thickness with an accompanying loss of cellularity and vascularity ([@R17]). In contrast, extrinsic aging, particularly photoaging (sun exposure), markedly affects both the epidermal and dermal layers, with the latter showing a striking loss of collagen and extracellular matrix ([@R41]; [@R43]). There is also accumulation of abnormal elastic tissues ([@R5]; [@R38]), which are due to formation of structurally different elastic fibers ([@R65]).

Senescent cells increase with age in both the epidermis and dermis, as determined by elevated levels of SA βgal activity and p16^INK4A^ expression ([@R14]; [@R28]; [@R44]; [@R64]). Because senescent cells cannot proliferate, their presence in aged skin can potentially impair tissue homeostasis, regeneration, and youthful tissue structure/function ([@R8]; [@R51]). For example, in a three dimensional organotypic culture model using neonatal dermal fibroblasts and epidermal keratinocytes from human donors of varying ages, increasing the expression of p16^INK4A^ in keratinocytes isolated from young (30--40 years) donors yielded a thin epidermal layer similar to that formed by keratinocytes from elderly (53--66 years) donors; decreasing the expression of p16^INK4A^ in keratinocytes from elderly donors transformed the aged skin phenotype of a thin epidermal layer into a thicker epidermis, similar to that formed by keratinocytes from young donors ([@R1]).

Aside from the cell autonomous effects of non-proliferating senescent cells on skin homeostasis, SASP factors secreted by senescent cells are also thought to contribute to skin aging phenotypes in a cell non autonomous manner. SASP factors, especially the matrix metalloproteinases (MMPs), become elevated with age and can alter the tissue microenvironment and accelerate skin aging phenotypes ([Table 1](#T1){ref-type="table"}). MMPs can degrade collagens, including type I collagen, which is the most abundant protein in the dermal extracellular matrix (ECM). Loss of collagen is associated with several clinical manifestations of aging skin, including wrinkles, sagging, and laxity ([@R24]; [@R43]; [@R50]). Hence, increased expression and activity of MMPs during aging can decrease the amount of collagen in the skin ([@R61]), diminish fibroblast collagen interactions, and reduce mechanical tension, explaining the wrinkling phenotype observed in aged skin ([@R60]). Another hypothesis for facial wrinkling is the enhanced elastase activity upon UVB stimuli, which is associated with a reduction in the elastic properties of the skin ([@R23]). The role of cellular senescence in promoting changes in the elastic tissue has not been addressed yet, but represents an important avenue for future clinical approaches.

While it is still unclear which specific stimuli are responsible for inducing cellular senescence during aging, both intrinsic and extrinsic aging have been linked to the age related increase in the number of senescent cells in the skin. For example, the hereditary disorders Werner syndrome, xeroderma pigmentosum, and Hutchinson--Gilford progeria syndrome, which are due to defects in DNA damage repair or nuclear organization, are associated with increased cellular senescence and accelerated age related phenotypes in the skin ([@R12]; [@R22]; [@R31]). Extrinsic factors, such as X-rays, ultraviolet (UV) light, and cigarette smoke, also can induce cellular senescence as well as age related phenotypes in the skin ([@R49]; [@R62]; [@R67]).

UV light can induce photoaging via direct damage to ECM components, such as collagen and fibrillin fibers ([@R24]; [@R36]; [@R48]), or indirect damage through mitochondrial dysfunction. Indeed, mitochondrial dysfunction is suggested to play a role in both intrinsic and extrinsic aging, and may potentially serve as a common link between the two ([@R30]). UV radiation induced photoaging of human skin is associated with large scale deletions in mitochondrial genomes (mtDNA) ([@R3]; [@R6]). Intra individual studies have revealed that the frequency of a 4,977 bp deletion, also defined as "common deletion", is increased up to 10 fold in photoaged skin compared with sun protected skin ([@R3]). The majority of these deletions are detectable in the dermis of human skin exposed to physiological doses of UVA ([@R4]). UV radiation also induces this common deletion in cultured skin fibroblasts and decreases mitochondrial function ([@R4]). Because mitochondrial damage and dysfunction induces cellular senescence in culture and *in vivo* ([@R39]; [@R62]), and UV light also promotes mitochondrial damage and cellular senescence, it would be interesting to test whether the UV-induced common deletion contributes to skin aging through mitochondrial dysfunction associated senescence.

Cellular senescence and wound healing {#S3}
=====================================

Wound healing is a complex process by which the skin repairs itself after injury. This process is classically divided into four distinct but overlapping phases ([@R52]): 1) hemostasis, 2) inflammation, 3) proliferation, and 4) remodeling. During the first two phases, platelets promote coagulation and begin an inflammatory cascade by secreting a variety of cytokines and chemokines to attract macrophages and neutrophils ([@R20]; [@R27]; [@R47]). Before the inflammatory phase ends, fibroblasts are recruited to the wound site and endothelial cells mature from progenitor cells to re establish vascularization ([@R9]; [@R40]; [@R53]). The proliferative phase begins with the formation of a granulation tissue and collagen deposition, and the wound closes by epithelialization and the contraction of differentiated myofibroblasts, which are specialized contractile fibroblasts ([@R21]). The final remodeling phase initiates when a stable ratio of collagen production and degradation is reached, and ends when the tissue acquires a mature organization and tensile strength after replacing transiently expressed collagen III with collagen I ([@R32]; [@R56]).

Recent findings using mouse models show that senescent cells are transiently induced in the granulation tissue during the proliferative phase of wound healing and are efficiently removed during the transition to the remodeling phase ([@R13]). Wound contraction is important for wound closure during the proliferative phase ([@R37]) and proceeds through the formation of newly synthesized granulation tissue and the activation of contraction in myofibroblasts ([@R56]). Thus, the presence of senescent cells within this window may be essential for proper wound healing. Indeed, the elimination of senescent cells in young mice bearing cutaneous wounds leads to poor formation of granulation tissue and a dramatic reduction in the number of myofibroblasts, with consequent delayed wound closure ([@R13]). Notably, this phenotype can be rescued in senescence-free mice by topical application of the SASP factor platelet derived growth factor AA (PDGF-AA), which promotes the differentiation and maturation of myofibroblasts. Senescence free wounds were also more fibrotic during the remodeling phase, but topical PDGF-AA was unable to limit this excessive fibrosis. These findings illustrate the complex and diverse roles played by senescent cells during wound healing, and suggest that other SASP factors in addition to PDGF-AA are important for optimal wound healing.

As indicated above, another important contribution of senescent fibroblasts during tissue repair is to limit fibrosis, which is commonly observed in chronic wounds and is characterized by excessive collagen deposition ([@R55]). Several MMPs, including MMP2, MMP3 and MMP9, are part of the SASP ([Table 1](#T1){ref-type="table"}) ([@R10]; [@R11]) and can degrade excess collagen and maintain tissue homeostasis during wound healing ([@R25]). Indeed, failure to induce senescence during wound healing causes fibrosis in the skin and liver ([@R25]; [@R26]; [@R29]). Overall, these results indicate that senescent cells can promote tissue repair through cell non autonomous mechanisms.

The irreversible growth arrest of senescent cells may restrict proliferation during wound healing as a means to protect against aberrant cell proliferation. This cell autonomous effect of senescent cells is in keeping with a fundamental role for cellular senescence in tumor suppression ([@R7]). Cells from mice lacking the p16^INK4a^ and p21^WAF1/CIP1^ genes are incapable of undergoing cellular senescence and highly susceptible to skin carcinogenesis upon DMBA/ TPA treatment due to their inability to arrest cell proliferation ([@R54]). Hence, the absence of cellular senescence may transform a wound into a hyperplastic or premalignant phenotype characterized by unregulated cell proliferation. Because wound healing and cancer share several molecular and cellular events ([@R16]; [@R18]), senescent cells may play an essential role in promoting wound healing while preventing cancer initiation.

While a lack of senescent cells impairs wound healing and can promote tumorigenesis, the persistent presence of senescent cells may exacerbate pathological diseases in the skin. For example, chronic wounds are characterized by the persistent presence of senescent cells in the wound areas ([@R35]; [@R58]; [@R59]). Because chronic wounds fail to progress through the different stages of the wound healing process ([@R46]), an excessive number of senescent cells may restrict cell proliferation and disrupt paracrine signaling cascades, thereby retarding the ability of wounds to resolve after injury. Moreover, some of the SASP factors that are important for wound healing seem to also promote cancer progression through cell non autonomous mechanisms. For example, certain MMPs that are anti fibrotic in wounds can also promote tumor cell invasion during the progression of skin cancers ([@R66]).

The balance between cell autonomous and non-autonomous effects in skin homeostasis {#S4}
==================================================================================

The complex role of senescent cells in the skin includes cell autonomous and non autonomous functions, which may be beneficial during wound healing but deleterious during aging ([Figure 1](#F1){ref-type="fig"}). What determines the phenotype of senescent cells and whether their effects on the tissue microenvironment are positive or negative? One hypothesis is that both the cell autonomous and non autonomous properties of senescent cells are highly dependent on age and time. First, the induction of an irreversible growth arrest might be an essential mechanism during wound healing that limits the number of highly proliferative cells, which are at risk for acquiring premalignant or malignant mutations. However, with time and age, this mechanism can exhaust the pool of proliferation competent stem or progenitor cells, which contribute to tissue turnover and regeneration. Second, the slow accumulation of senescent cells in the skin due to increased number and/or defective clearance might create chronic inflammation and promote age associated skin pathologies, for example through the chronic production of MMPs. Third, the SASP may be a malleable phenotype and change over time and with age. Thus, harmful cytokines, chemokines and other inflammatory factors may be secreted by senescent cells only when they are persistently present in the skin.

Conclusion {#S5}
==========

The elimination of senescent cells is an attractive avenue for developing new interventions to treat age-related pathologies, and several laboratories are searching for small molecules that might be of potential interest for future clinical studies (see ([@R15]) for an example). In the skin, the different roles of senescent cells in promoting both physiological and pathophysiological conditions are still in early phases of discovery. More experiments need to be done to determine how senescent cells can tip the balance between efficient and chronic wound healing. It also remains to be proven whether presence of long-lived versus short-lived senescent cells plays a major contributory factor to this difference. Thus, whether and how an anti-senescence approach will help maintain healthy skin awaits future experimentation. While the elimination of senescent cells might reduce age-related chronic inflammation and collagen degradation, this strategy could fail to restore youthful skin phenotypes that depend on adequate stem cell numbers. Finding ways to replenish these stem cells may be necessary in order to rescue age-related skin defects after the elimination of senescent cells. Furthermore, the continuous removal of senescent cells in the skin, particularly in the elderly, could impede wound healing and increase tissue scarring, which are of bigger concerns than having a youthful looking skin. Hence, a better understanding of the complexity of the cell autonomous and non-autonomous functions of senescent cells, and the mechanisms that lead to their induction, will be essential in order to develop specific therapeutic approaches with minimal side effects to treat age-related skin phenotypes and pathologies.
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![Senescent cells act in the skin via both cell autonomous and non-autonomous mechanisms\
The transient induction of cellular senescence during wound healing promotes granulation tissue formation and tissue remodeling, while it prevents the hyperproliferation of potentially premalignant or malignant lesions. In contrast, the accumulation of senescent cells with age causes poor tissue regeneration and loss of homeostasis in the skin. The chronic presence of senescent cells further creates a tissue environment with chronic inflammation promotes collagen degradation, both of which can lead to aging phenotypes in the skin.](nihms-671632-f0001){#F1}

###### 

List of MMPs involved in skin aging, cellular senescence, and wound healing

  -------------------------------------------------------------------
                      MMP Expression               References
  ------------------- ---------------------------- ------------------
  **Skin Aging**      Elevated Expression of\      ([@R42])
                      MMP1, MMP3, and MMP9         

  **Cellular**\       Elevated Expression of\      ([@R10]; [@R19])
  **Senescence**      MMP1, MMP3, MMP8,\           
                      MMP10, MMP12, and\           
                      MMP13                        

  **Wound Healing**   Temporal Up-regulation of\   ([@R34])
                      MMP1, MMP2, MMP9,\           
                      MMP3, MMP10, MMP14,\         
                      MMP8, MMP12, MMP13,\         
                      MMP19, MMP26, MMP28          
  -------------------------------------------------------------------
